抗CCR7单链抗体的筛选及初步鉴定

Screening and primary identification of anti-CCR7 scFv from large phage library

目的从噬菌体抗体库中筛选抗CCR7单链融合抗体,并对其生物学特性进行初步检测。方法PCR检测大肠杆菌中ScFv基因插入率;琼脂糖凝胶电泳鉴定SfiI和NotI双酶切质粒的结果;分别以乳腺癌细胞及CCR7多肽片段为靶抗原对抗体库进行4轮和3轮筛选富集。将阳性克隆转化E.coliHB2151进行可溶表达。抗体亲和层析纯化后,经Western blot鉴定,通过ELISA法检测可溶性ScFv抗体的免疫活性。免疫细胞化学和放射免疫显像鉴定scFv抗体与乳腺癌细胞结合的特异性。结果ScFv基因插入率为90%(18/20),双酶切鉴定检测到目的条带。经4轮细胞筛选,3轮抗原筛选抗CCR7抗原的噬菌体抗体得到了明显富集,在E.coliHB2151中实现可溶表达。Western blot结果显示获得抗体相对分子质量为34ku左右。免疫细胞化学检测与放射免疫显像均证实单链抗体与表达CCR7的乳腺癌细胞MDA-MB-435s特异性结合。结论成功从噬菌体抗体库中筛选获得具有较高特异性的抗CCR7单链抗体。抗体在体内体外均与肿瘤细胞表达特异抗原结合。

Aim To screen and identify anti-CCR7 single chain fragments variable（scFv）from lager phage library and to detect the scFv efficiency.Methods The insert ratio of ScFv antibodies library was identified by PCR.The products digested by Sfi I/Not I double enzyme.Panning against breast cancer cell and CCR7 were performed four and three rounds respectively.Positive clones were transformed to E.coli HB2151,and their dissolvability was assayed.The soluble scFv was purified by affinity chromatography,and its relative molecular mass was determined by Western blot.The ELISA assay was used to identify the immunocompetence of the antibody.Immunocytochemical staining and radioimmunoimaging were employed to determine the affinities of scFv binding with CCR7 in cell line and in nude mice.Results The insert ratio of ScFv gene was 90%（18/20）,enzyme digest reaction showed the aim products on 1% agarose gel.ScFvs were obviously enriched after 7 round panning.Western blot result showed soluble scFv＇s molecular mass was about 34 KD.ELISA analysis showed dissolved antibody had high immunocompetence to MDA-MB-435 s cells.Immunocytochemical staining and radioimmunoimaging indicated that ScFvs were bound efficiently to MDA-MB-435 s cells which expressed CCR7.Conclusions ScFvs against CCR7 are successfully acquired by screening the phage antibody library.The soluble ScFvs have high affinity and specifical binding to human breast cancer cells.